It may be a #NewYear, but our resolution remains the same: through our fiercely patient-centric approach, we are still working tirelessly to create greatly needed research infrastructure to improve the outcomes and care for #RareCancer patients. 💚💙
Diversity in data is key to making progress in the development of vital #RareCancer treatments. Representation in research leads to better health outcomes for everyone! 🤝
Here at RCRF, we’re working to achieve better health equity for ALL rare cancer patients. Join us today.
According to our partner the Chondrosarcoma Foundation, only ~19% of rare cancer patients receive genomic sequencing. 🧬
Here at RCRF, we're working to change that. We believe that every #RareCancer patient should have access to this increasingly important information.
RCRF is fiercely patient-centric.
Tissue donated through https://t.co/wlPafYimhs has helped to create over 58 rare cancer research models and counting!
As Jane says, it’s a game changer. 🤝
Today is #GivingTuesday2024, and we hope you will consider us in your donation plans as we work to improve outcomes for #RareCancer patients.
Learn more and give today at the link in our bio! 💙💚
We’re working to accelerate transformative advances in #RareCancer treatment and we need your help. Tomorrow Can’t Wait. Please consider us in your end-of-year giving and join us today! 💙💚
👉 https://t.co/neW5epDy3c
We're proud to announce we've been selected as an @ARPA_H Investor Catalyst Hub spoke: connecting researchers, entrepreneurs, & investors to accelerate solutions for innovative biomedical solutions! Excited to bring our expertise in rare cancer research to https://t.co/jpUGKZIjvv
Happening TODAY at 12pm CT: Live (free) webinar, "Innovations in Rare Cancers," - RCRF President, Dr. Marshall Thompson, will join the panel discussion to share his perspectives on the most pressing issues in rare caner research! Register to join:
https://t.co/yo8pkMXzQf
Check out this article featuring a few of our team members! Our own @kaydaustin explains how she turned her diagnosis into a mission to help people with #rarecancers.
“My whole clinical history was just sitting there, and nobody was learning from it.” New platforms empower patients to use their clinical data and tissue for cancer research. https://t.co/LpDIzf4kKx @corrie_painter@RareCancerRF@kaydaustin
Several members of the RCRF team are quoted in this @CancerTodayMag feature on "Patients as Research Partners," which discusses patient-driven rare cancer research programs, such as our https://t.co/wlPafYimhs program & The Broad Institute's Count Me In:
https://t.co/bDUSPAVtoL
Want to take control of your data? Join us today on #RareCancerDay to sign up to #DonateYourData to the first patient-powered data commons- a resource that will help researchers accelerate discovery for #rarecancers: https://t.co/uaImTmn8Xb
Our Pattern Data Commons will allow patients to donate their data by consenting to have RCRF collect medical records & sequencing data through a secure online platform. Sign up to learn more & #DonateYourData: https://t.co/uaImTmn8Xb 2/2
We announced today on #RareCancerDay that we’ll be launching the Pattern Data Commons - a patient-powered data repository that will help researchers accelerate discovery for #rarecancers…1/2